Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FX4J3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,219
Award facts
- Contract value 100% obligated
- $19,218.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,218.87 firm fixed-price delivery order to AmerSourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. This order, which was competitively awarded without set-aside designation, has an ultimate completion date of January 21, 2026, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. REPATHA (evolocumab) is a PCSK9 inhibitor prescribed for cholesterol management and cardiovascular disease prevention, representing a specialty pharmaceutical product within the company's extensive medical supply portfolio.
This delivery order is issued under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2031. This strategic vehicle enables the pharmaceutical distributor to supply a comprehensive range of medications, medical devices, and healthcare commodities to military treatment facilities and other federal healthcare systems globally. The competitively awarded structure and firm fixed-price arrangement reflect DLA's approach to procuring specialized pharmaceutical products necessary for military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FX4J3?
SPE2DR26FX4J3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FX4J3 worth?
The government has obligated $19,219 on SPE2DR26FX4J3.
Is contract SPE2DR26FX4J3 an order under another contract?
Yes. SPE2DR26FX4J3 is a delivery order under SPE2DR25D2218, an indefinite delivery contract.
Was contract SPE2DR26FX4J3 competed?
The extent of competition for SPE2DR26FX4J3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award